Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Payables: 2013-2019

Historic Payables for Soleno Therapeutics (SLNO) over the last 5 years, with Sep 2019 value amounting to $1.7 million.

  • Soleno Therapeutics' Payables rose 39.36% to $1.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $5.7 million, marking a year-over-year increase of 41.96%. This contributed to the annual value of $934,000 for FY2018, which is 47.55% up from last year.
  • According to the latest figures from Q3 2019, Soleno Therapeutics' Payables is $1.7 million, which was down 0.29% from $1.7 million recorded in Q2 2019.
  • Soleno Therapeutics' Payables' 5-year high stood at $1.7 million during Q2 2019, with a 5-year trough of $410,512 in Q4 2016.
  • In the last 3 years, Soleno Therapeutics' Payables had a median value of $1.0 million in 2017 and averaged $1.1 million.
  • The largest annual percentage gain for Soleno Therapeutics' Payables in the last 5 years was 103.22% (2016), contrasted with its biggest fall of 40.94% (2016).
  • Soleno Therapeutics' Payables (Quarterly) stood at $695,056 in 2015, then slumped by 40.94% to $410,512 in 2016, then surged by 54.20% to $633,000 in 2017, then surged by 47.55% to $934,000 in 2018, then surged by 39.36% to $1.7 million in 2019.
  • Its Payables was $1.7 million in Q3 2019, compared to $1.7 million in Q2 2019 and $1.3 million in Q1 2019.